XYLT1 and cystic fibrosis: Based on prior publications [31, 32, 50], it is likely that the in vivo exposure of these cytokines and growth factors could have led to epigenetic changes, including miRNA expression and histone modifications, affecting the relative basal expression of XYLT1 in AFib and CF.